IL6 and tuberculosis: On the 180th day after therapy, the level of IL-6 expression in the HIV/TB group was 11.3 times higher compared to the control group and the TB group, and 8.96 times higher compared to the group of patients with HIV monoinfection (p = 0.001; p = 0.001; p = 0.001, respectively), actually remaining at the same level as before the initiation of therapy.